Drug Approval Package

Letairis (Ambrisentan) Tablets
Company:  Gilead Sciences, Inc.
Application No.:  022081
Approval Date: 06/15/2007

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  

• Statistical Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  
  Part 4 (PDF)  
  Part 5 (PDF)  
  Part 6 (PDF)  
  Part 7 (PDF)  
  Part 8 (PDF)  

• Administrative Document(s) & Correspondence (PDF)  

Date created:  August 21, 2007

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.